Caribou Biosciences $3.9 Million Securities Settlement

If you purchased Caribou Biosciences, Inc. common stock between July 23, 2021, and July 13, 2023, you may be eligible to claim a portion of a $3,900,000 class action settlement.

Caribou Biosciences, Inc. has agreed to settle a class action lawsuit due to alleged misrepresentations and omissions in their public statements and filings with the U.S. Securities and Exchange Commission.

Who can file a claim?

• Individuals or entities who bought Caribou common stock between July 23, 2021, and July 13, 2023.
• Those who purchased Caribou common stock pursuant to or traceable to the July 2021 initial public offering.

How much can class members get?

The settlement fund of $3,900,000 will be distributed among class members who submit valid claims. The amount each member receives will depend on several factors, including the number of shares purchased and sold, and the timing of these transactions.

• Recognized Loss Calculation: The recognized loss per share will be calculated based on the difference between the purchase price and the sale price, adjusted for any inflationary impact as outlined in the settlement.
• Pro Rata Distribution: If the total recognized losses exceed the net settlement fund, payments will be distributed on a pro rata basis. For example, if a claimant's recognized loss is 5% of the total recognized losses, they will receive 5% of the net settlement fund.

How to claim an award

To claim an award, class members must submit a Proof of Claim and Release Form. This can be done online through the online claim form or by downloading the PDF claim form and mailing it to the Claims Administrator.

Caribou Biosciences, Inc. Securities Litigation

c/o Strategic Claims Services

P.O. Box 230

600 N. Jackson St., Ste. 205

Media, PA 19063

Claimants need to provide proof of their transactions in Caribou common stock. This includes:

• Stockbroker's confirmation slips or statements.
• Documentation of each purchase and sale during the class period.

Claimants must ensure their forms are submitted by January 17, 2025.

Payment methods

• Check
• Direct deposit

$3,900,000 Settlement fund

The settlement fund of $3,900,000 will cover:

• Attorneys' fees up to $1,092,000
• Litigation expenses not exceeding $60,000
• Compensatory awards to plaintiffs totaling $7,500
• Remaining funds will be distributed to class members

Important dates

• Deadline to File a Claim: January 17, 2025
• Final Approval Hearing: February 18, 2025

When is the Caribou Biosciences Settlement payout date?

The payout date will be determined after the final approval hearing, scheduled for February 18, 2025. If the settlement is approved, payments will be distributed to eligible class members.

Why is there a class action settlement?

The lawsuit alleged that Caribou Biosciences made false or misleading statements in their public filings, which inflated the stock price. The settlement was reached to avoid the risks and costs associated with continued litigation.